Implication of ESC/EAS 2019 dyslipidemia guidelines for PCSK9 inhibition in patients with familial hypercholesterolemia: An analysis from the Hellas-FH registry
| Autor: | Rizos, C., Skoumas, I., Skalides, E., Rallidis, L., Tziomalos, K., Sfikas, G., Garoufi, A., Anagnostis, P., Kolovou, G., Kotsis, V., Doumas, M., Bilianou, E., Koutagiar, I., Zacharis, E., Kiouri, E., Bantouvakis, G., Agapakis, D., Attilakos, A., Antza, C., Liberopoulos, E.N. |
|---|---|
| Zdroj: | In Atherosclerosis August 2021 331:e51-e51 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect